Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: A randomized controlled trial in non-diabetes stage 4 chronic kidney disease

Mao, Wei; Zhang, Lei; Zou, Chuan; Wu, Yifan; Wu, Yuchi; Xu, Peng; Zhao, Daixin; Zhang, La; Li, Chuang; Su, Guobin; Guo, Xinfeng; Lu, Fuhua; Lin, Qizhan; Wang, Lixin; Bao, Kun; Peng, Yu; Liang, Hui; Lu, Zhaoyu; Gao, Yanxiang; Jie, Xina; Wen, Zehuai; Liu, Xusheng

Published in

BioMed Central, BMC Complementary and Alternative Medicine, 1(15)

DOI: 10.1186/s12906-015-0830-1

Tools

Export citation

Search in Google Scholar

Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: A randomized controlled trial in non-diabetes stage 4 chronic kidney disease

Journal article published in 2015 by Wei Mao, Lei Zhang, Chuan Zou, Yifan Wu, Yuchi Wu, Peng Xu, Daixin Zhao, La Zhang, Chuang Li, Guobin Su, Xinfeng Guo, Fuhua Lu, Qizhan Lin, Lixin Wang, Kun Bao and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: A randomized controlled trial in non-diabetes stage 4 chronic kidney disease